The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.13 as of 2026Q1, though this is offset by a substantial accumulated deficit of $295.8 million.
| Total Current Assets | 69.76M | 104.21M | 69.06M | 41.9M | 62.02M | 77.02M | 97.74M | 22.84M | 27.84M | 14M | 16.72M | 15.08M | 1.47M |
| Cash & Short-Term Investments | 50.46M | 81.8M | 54.91M | 26.21M | 46.52M | 67.06M | 83.91M | 14.82M | 22.53M | 8.83M | 15.5M | 14.79M | 1.47M |
| Cash Only | 50.46M | 81.8M | 54.91M | 26.21M | 46.52M | 67.06M | 83.91M | 14.82M | 22.53M | 8.83M | 15.5M | 7.58M | 1.47M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.21M | 0 |
| Accounts Receivable | 9.45M | 9.86M | 7.04M | 7.29M | 6.34M | 1.41M | 7.43M | 3.31M | 1.52M | 3.57M | 5.7M | 0 | 0 |
| Days Sales Outstanding | 157.66 | 223.59 | 252.91 | 369.51 | 346.59 | 74.88 | 371.35 | 289.84 | 289.58 | 334.27 | - | - | - |
| Inventory | 9.03M | 11.28M | 5.8M | 6.99M | 7.94M | 7.4M | 5.33M | 3.67M | 2.67M | 1.14M | 310.11K | 0 | 0 |
| Days Inventory Outstanding | 622.85 | 875.3 | 610.53 | 905.57 | 791.93 | 689.13 | 508.05 | 751.72 | 745.31 | 172.27 | 605.27 | - | - |
| Other Current Assets | 813.67K | 1.27M | 0 | 0 | 0 | 1.15M | 1.07M | 1.03M | 224.87K | 458.07K | 518.49K | 100.39K | 148.42K |
| Total Non-Current Assets | 3.94M | 88.73M | 1.17M | 2.06M | 2.4M | 9.64M | 6.86M | 7.27M | 6.34M | 8.17M | 904.48K | 188.52K | 213.63K |
| Property, Plant & Equipment | 3.59M | 225K | 821.01K | 1.57M | 1.72M | 1.9M | 2.28M | 2.22M | 886.44K | 1.37M | 709.05K | 165.1K | 178.63K |
| Fixed Asset Turnover | 15.07x | 71.55x | 12.38x | 4.59x | 3.89x | 3.61x | 3.20x | 1.88x | 2.16x | 2.84x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 2.69M | 2.68M | 2.63M | 2.5M | 2.71M | 0 | 0 | 0 |
| Intangible Assets | 129.42K | 138K | 261K | 490K | 680K | 1.43M | 1.9M | 2.41M | 2.95M | 4.09M | 195.44K | 23.42K | 35K |
| Long-Term Investments | 561.38K | 410.89K | 0 | 0 | 0 | 3.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 87.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -213.63K |
| Total Assets | 73.7M | 192.94M | 70.23M | 43.96M | 64.42M | 86.66M | 104.6M | 30.11M | 34.18M | 22.17M | 17.63M | 15.27M | 1.47M |
| Asset Turnover | 0.21x | 0.08x | 0.14x | 0.16x | 0.10x | 0.08x | 0.07x | 0.14x | 0.06x | 0.18x | - | - | - |
| Asset Growth % | 168.52% | 174.71% | 59.78% | -31.77% | -25.66% | -17.15% | 247.42% | -11.91% | 54.15% | 25.77% | 15.44% | 938.08% | - |
| Total Current Liabilities | 10.64M | 8.32M | 6.57M | 6.37M | 4.18M | 4.15M | 4.81M | 8.24M | 5.79M | 8.53M | 3.68M | 913.01K | 102.73K |
| Accounts Payable | 2.15M | 2.14M | 1.32M | 865K | 2.03M | 3.18M | 3.38M | 3.03M | 2.87M | 4.04M | 1.32M | 0 | 9.18K |
| Days Payables Outstanding | 100.25 | 166.07 | 138.61 | 112.08 | 202.74 | 295.62 | 322.31 | 620.55 | 802.93 | 611.71 | 2.58K | - | - |
| Short-Term Debt | 4.59M | 291.73K | 1.74M | 2.1M | 523K | 249.66K | 312K | 4.17M | 983.52K | 3.74M | 2.14M | 206.6K | 830.05K |
| Deferred Revenue (Current) | 2.2M | 0 | 419K | 721K | 471K | 476.35K | 358K | 504.93K | 229.48K | 191.9K | 192.91K | 0 | 0 |
| Other Current Liabilities | 1.69M | 5.83M | 1.03M | 1.42M | 621K | 247.66K | 744K | 521.75K | 1.48M | 586.19K | 29.28K | 706.41K | -830.05K |
| Current Ratio | 6.56x | 12.52x | 10.52x | 6.58x | 14.82x | 18.56x | 20.32x | 2.77x | 4.81x | 1.64x | 4.54x | 16.52x | 14.32x |
| Quick Ratio | 5.71x | 11.17x | 9.64x | 5.48x | 12.92x | 16.78x | 19.22x | 2.33x | 4.35x | 1.51x | 4.46x | 16.52x | 14.32x |
| Cash Conversion Cycle | 680.27 | 932.83 | 724.83 | 1.16K | 935.77 | 468.39 | 557.09 | 421.01 | 231.96 | -105.16 | - | - | - |
| Total Non-Current Liabilities | 3.44M | 93.63M | 3.25M | 6.36M | 8.23M | 2M | 2.44M | 7.48M | 8.84M | 2.4M | 2.91M | 4.29M | 2.68M |
| Long-Term Debt | 0 | 6.16M | 2.92M | 5M | 6.65M | 0 | 0 | 5.18M | 10.62M | 352.98K | 3.87M | 5.56M | 1.95M |
| Capital Lease Obligations | 2.97M | 0 | 203K | 504K | 817K | 1.13M | 1.36M | 1.64M | -2.82M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 86.83M | 86.83M | 0 | 59K | 0 | 0 | 0 | 0 | 250.64K | -284.95K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 92.3K | 108.2K | 71K | 73K | 0 | 0 | 0 | 14.65K | -2.3M | 2.04M | -961.24K | -1.27M | -1.95M |
| Total Liabilities | 14.08M | 101.95M | 9.81M | 12.73M | 12.42M | 6.15M | 7.25M | 15.71M | 14.63M | 10.93M | 6.59M | 5.21M | 102.73K |
| Total Debt | 7.49M | 6.45M | 5.12M | 7.87M | 8.23M | 1.38M | 1.68M | 10.99M | 8.78M | 4.09M | 4.94M | 4.21M | 2.78M |
| Net Debt | -42.97M | -75.34M | -49.79M | -18.35M | -38.29M | -65.69M | -82.24M | -3.84M | -13.75M | -4.74M | -10.56M | -3.37M | 1.31M |
| Debt / Equity | 0.13x | 0.07x | 0.08x | 0.25x | 0.16x | 0.02x | 0.02x | 0.76x | 0.45x | 0.36x | 0.45x | 0.42x | 2.03x |
| Debt / EBITDA | -0.20x | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 1.15x | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -36.27x | -168.80x | -459.67x | -38.74x | -13.52x | -18.96x | -12.91x | -25.57x | -2.88x | -44.74x |
| Total Equity | 59.62M | 90.99M | 60.42M | 31.22M | 52M | 80.51M | 97.35M | 14.39M | 19.55M | 11.25M | 11.04M | 10.06M | 1.37M |
| Equity Growth % | 44.57% | 50.59% | 93.51% | -39.96% | -35.41% | -17.3% | 576.36% | -26.37% | 73.84% | 1.88% | 9.7% | 635.46% | - |
| Book Value per Share | 1.64 | 3.01 | 2.44 | 1.47 | 2.50 | 3.93 | 5.63 | 1.30 | 1.95 | 1.83 | 2.66 | 4.25 | 6.31 |
| Total Shareholders' Equity | 59.62M | 90.99M | 60.42M | 31.22M | 52M | 80.51M | 97.35M | 14.39M | 19.55M | 11.25M | 11.04M | 10.06M | 1.37M |
| Common Stock | 325.23M | 443.54M | 281.55M | 222.21M | 205.82M | 219.28M | 211.53M | 100.46M | 88.79M | 78.22M | 61.95M | 48.34M | 1.54M |
| Retained Earnings | -295.76M | -394.1M | -245.17M | -217.35M | -189.36M | -160.48M | -129.99M | -101.07M | -81.52M | -71.79M | -53.16M | -39.72M | -453.15K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.85M | 0 | 0 | 0 |
| Accumulated OCI | 4.03M | 6.88M | 2.74M | 5.57M | 16.84M | 4.74M | 4.57M | -90.37K | -21.07K | -46.07K | 8.42K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Persistent operational cash burn
According to recent financial filings, PROF's total assets have exhibited significant volatility, peaking at $192.9M in 2025Q4 before contracting to $73.7M in 2026Q1, a trend that reflects the company's reliance on periodic capital raises to fund its ongoing commercial expansion and clinical development efforts.
The sharp contraction in total assets suggests that the company is actively consuming its capital base to support operations rather than building long-term asset value. Investors should monitor whether this volatility stabilizes as the company moves toward a more predictable revenue model.
As reported in financial statements, PROF maintains a robust liquidity position with $50.5M in cash as of 2026Q1, providing a substantial buffer against its current operating losses and ensuring the company retains sufficient runway to continue its commercialization strategy without immediate reliance on external financing.
The current ratio of 6.56 indicates a high level of short-term solvency, which is critical for a company in the early-commercial stage. This liquidity profile suggests management is prioritizing operational flexibility over aggressive balance sheet optimization at this stage of the business cycle.
Based on PROF's reported figures, the company maintains a conservative capital structure with debt levels remaining low, as evidenced by a debt-to-equity ratio of 0.13 in 2026Q1, which indicates that the firm is not currently burdened by significant interest obligations or restrictive debt covenants.
The minimal reliance on debt appears to be a strategic choice, allowing the company to avoid the risks associated with high leverage during a period of negative operating margins. This lack of debt provides a clean balance sheet that could facilitate future financing if necessary.
As indicated by historical balance sheet data, PROF's equity base is significantly impacted by a persistent and growing accumulated deficit, which reached -$295.8M in 2026Q1, highlighting the substantial historical investment required to bring the TULSA-PRO system to its current commercial stage.
The erosion of retained earnings underscores the high cost of market entry and the long-term nature of the company's R&D and commercialization investments. Future equity quality will depend heavily on the company's ability to transition from these deep losses to sustainable profitability.
Quick answers to the most common questions about buying PROF stock.
As of 2025, Profound Medical Corp. (PROF) had total assets of $192.9M including $104.2M in current assets.
Profound Medical Corp. (PROF) carries total debt of $6.5M, offset by $81.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Profound Medical Corp. (PROF) has total shareholders' equity (book value) of $91.0M ($3.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Profound Medical Corp. (PROF) reported a current ratio of 12.52x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.